Avioq

Avioq is a US-based, private diagnostic company and CDMO founded in 2005 and headquartered in Research Triangle Park, North Carolina. It has a portfolio of FDA-approved and CE-marked assays for HIV and HTLV and leverages its regulatory expertise and certified manufacturing facility to offer end-to-end IVD development and manufacturing services to other companies. The company's business model combines revenue from its own commercial diagnostic products with fee-for-service CDMO work, positioning it in the growing market for outsourced IVD development and direct-to-consumer testing.

Proven immunoassay (ELISA) development and manufacturing platform for infectious disease diagnostics, utilizing recombinant antigens, viral lysates, and monoclonal antibodies. Integrated quality and regulatory process for IVD development from concept to FDA/CE approval.

Avioq competes in the fragmented IVD CDMO market against larger players like Thermo Fisher Scientific and Charles River Laboratories, as well as specialized diagnostic CMOs. Its differentiation lies in its specific FDA BLA license for manufacturing, hands-on regulatory experience, and a focus on end-to-end service from development to commercial production.